HomeInsightsStock Comparison

Hester Biosciences Ltd vs Mankind Pharma Ltd Stock Comparison

Hester Biosciences Ltd vs Mankind Pharma Ltd Stock Comparison

Last Updated on: Jul 16, 2025

Key Highlights

  • The Latest Trading Price of Hester Biosciences Ltd is ₹ 1861 as of 16 Jul 15:30.
  • The P/E Ratio of Hester Biosciences Ltd changed from 27 on March 2020 to 38.8 on March 2025 . This represents a CAGR of 6.23% over 6 yearsThe P/E Ratio of Mankind Pharma Ltd changed from 48.1 on March 2024 to 0 on March 2025 . This represents a CAGR of -100.00% over 2 years.
  • The Market Cap of Hester Biosciences Ltd changed from ₹ 786.93 crore on March 2020 to ₹ 1066 crore on March 2025 . This represents a CAGR of 5.20% over 6 yearsThe Market Cap of Mankind Pharma Ltd changed from ₹ 92029 crore on March 2024 to ₹ 0 crore on March 2025 . This represents a CAGR of -100.00% over 2 years.
  • The revenue of Hester Biosciences Ltd for the Mar '25 is ₹ 76.29 crore as compare to the Dec '24 revenue of ₹ 72 crore. This represent the growth of 5.96% The revenue of Mankind Pharma Ltd for the Mar '25 is ₹ 3333 crore as compare to the Dec '24 revenue of ₹ 3285 crore. This represent the growth of 1.43%.
  • The ebitda of Hester Biosciences Ltd for the Mar '25 is ₹ 13.54 crore as compare to the Dec '24 ebitda of ₹ 13.85 crore. This represent the decline of -2.24% The ebitda of Mankind Pharma Ltd for the Mar '25 is ₹ 932.5 crore as compare to the Dec '24 ebitda of ₹ 903.08 crore. This represent the growth of 3.26%.
  • The net profit of Hester Biosciences Ltd changed from ₹ 6.71 crore to ₹ 1.54 crore over 8 quarters. This represents a CAGR of -52.09% The net profit of Mankind Pharma Ltd changed from ₹ 494.19 crore to ₹ 424.65 crore over 8 quarters. This represents a CAGR of -7.30% .
  • The Dividend Payout of Hester Biosciences Ltd changed from 17.99 % on March 2020 to 18.71 % on March 2025 . This represents a CAGR of 0.66% over 6 yearsThe Dividend Payout of Mankind Pharma Ltd changed from 31.56 % on March 2020 to 0 % on March 2025 . This represents a CAGR of -100.00% over 6 years.

Share Price

* All values are in Rupees

P/E Ratio Over Time

No data available

Market Cap Over Time

No data available

* All values are in crore

Historical Share Prices

* All values are in Rupees

Revenue Over Time

No data available

* All values are in crore

EBITDA Over Time

No data available

* All values are in crore

Net Profit Over Time

No data available

* All values are in crore

Dividend Payout Over Time

No data available

* All values are in %

About Hester Biosciences Ltd

  • Hester Biosciences Limited is one of the leading and pioneering animal healthcare companies in India.
  • The Company was incorporated in April, 1987 and is principally engaged in manufacturing of Poultry vaccines and Large Animal Vaccines and trading of Poultry and Large animal and Petcare health products having its manufacturing set up at Meda Adraj Village, Mehsana District, Gujarat. The Company engages in two business verticals, namely Poultry Healthcare and Animal Healthcare.
  • It has built a presence in several regions of Africa and in numerous nations, including Vietnam, Indonesia, Nepal, and Bangladesh.
  • The products and services offered include over 51 vaccines and 70+ health products.
  • In addition, it offers a vast selection of pharmaceuticals, feed supplements, and disinfectants for poultry and large animals.

About Mankind Pharma Ltd

  • Mankind Pharma Limited was incorporated on July 3, 1991, as a Private Limited Company with the name 'Mankind Pharma Private Limited', by the Registrar of Companies, Delhi and Haryana, at New Delhi.
  • Pursuant to conversion of Company to a Public Limited dated July 14, 2005, name of the Company was changed to 'Mankind Pharma Limited' and the RoC issued a fresh Certificate of Incorporation on April 13, 2006. The Company is engaged in developing, manufacturing and marketing a diverse range of pharmaceutical formulations and chronic therapeutic areas across, as well as several consumer healthcare products.
  • It is present in several acute and chronic therapeutic areas in India, including anti-infectives, cardiovascular, gastrointestinal, anti-diabetic, neuro/CNS, vitamins /minerals / nutrients and respiratory.

Hester Biosciences Ltd News Hub

News

Hester Biosciences AGM scheduled

Hester Biosciences announced that the 38th Annual General Meeting(AGM) of the company will...

Read more

11 Jul 2025 17:41

News

Board of Hester Biosciences recommends final dividend

Hester Biosciences announced that the Board of Directors of the Company at its meeting hel...

Read more

09 May 2025 13:50

News

Hester Biosciences registers 30% YoY jump in Q4 PAT PAT to Rs 9.6 crore

The Animal Division, which includes both Ruminants and Pet health products, reported an 8%...

Read more

09 May 2025 13:56

News

Hester Biosciences to conduct board meeting

Hester Biosciences will hold a meeting of the Board of Directors of the Company on 9 May 2...

Read more

02 May 2025 14:01

News

Hester Biosciences to declare Quarterly Result

Hester Biosciences will hold a meeting of the Board of Directors of the Company on 30 Janu...

Read more

23 Jan 2025 09:45

News

Hester Biosciences receives reaffirmation in credit rating for bank facilities

Hester Biosciences has received reaffirmation in credit ratings for bank facilities at CAR...

Read more

20 Dec 2024 13:44

Mankind Pharma Ltd News Hub

News

Mankind Pharma to convene board meeting

Mankind Pharma will hold a meeting of the Board of Directors of the Company on 31 July 202...

Read more

15 Jul 2025 10:48

News

Mankind Pharma Ltd spurts 2.92%, gains for five straight sessions

Mankind Pharma Ltd rose for a fifth straight session today. The stock is quoting at Rs 265...

Read more

14 Jul 2025 13:00

News

Mankind Pharma AGM scheduled

Mankind Pharma announced that the 34th Annual General Meeting(AGM) of the company will be ...

Read more

04 Jul 2025 16:31

News

Mankind Pharma allots 57,709 equity shares under ESOP

Mankind Pharma has allotted 57,709 equity shares of face value of Re. 1/- each of the Comp...

Read more

10 Jun 2025 13:26

News

Mankind Pharma Ltd slips for fifth straight session

Mankind Pharma Ltd is down for a fifth straight session today. The stock is quoting at Rs ...

Read more

23 May 2025 13:35

News

Mankind Pharma slides after Q4 PAT drops 11% YoY to Rs 421 cr

However, revenue from operations increased 27.19% year-on-year (YoY) to Rs 3,079.37 crore ...

Read more

22 May 2025 15:37

SWOT Analysis Of Mankind Pharma Ltd

Strength

1

S

Weakness

2

W

Opportunity

0

O

Threats

0

T

SWOT Analysis Of Hester Biosciences Ltd

Strength

3

S

Weakness

1

W

Opportunity

0

O

Threats

1

T

BlinkX Score for Mankind Pharma Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

BlinkX Score for Hester Biosciences Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

FAQs for the comparison of Hester Biosciences Ltd and Mankind Pharma Ltd

Which company has a larger market capitalization, Hester Biosciences Ltd or Mankind Pharma Ltd?

Market cap of Hester Biosciences Ltd is 1,600 Cr while Market cap of Mankind Pharma Ltd is 109,463 Cr

What are the key factors driving the stock performance of Hester Biosciences Ltd and Mankind Pharma Ltd?

The stock performance of Hester Biosciences Ltd and Mankind Pharma Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Hester Biosciences Ltd and Mankind Pharma Ltd?

As of July 16, 2025, the Hester Biosciences Ltd stock price is INR ₹1881.75. On the other hand, Mankind Pharma Ltd stock price is INR ₹2652.2.

How do dividend payouts of Hester Biosciences Ltd and Mankind Pharma Ltd compare?

To compare the dividend payouts of Hester Biosciences Ltd and Mankind Pharma Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions